Pain and stiffness come with age, but when it becomes severe and appears rapidly, it might be an indication of polymyalgia rheumatic, an inflammatory disorder. This condition can lead to a dramatic ...

Polymyalgia rheumatica (PMR) is an inflammatory disorder that causes severe muscle pain, muscle stiffness, muscle spasms and cramping on both sides of the body, particularly in the shoulders, neck, ...

In this article, Lally and colleagues present the results of an open-label trial of the anti-interleukin (IL)-6 receptor agent tocilizumab in 10 patients with isolated polymyalgia rheumatica (PMR).

Background: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an ...

Please provide your email address to receive an email when new articles are posted on . Patients were more likely to achieve sustained remission with sarilumab vs. placebo. The most common adverse ...

The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper. The Food and ...

Discover top medications for 'treating Polymyalgia Rheumatica'? This page compiles essential information on generic and brand-name drugs specifically used for Polymyalgia Rheumatica treatment.Here, ...

Tofacitinib (Xeljanz) appeared highly effective against polymyalgia rheumatica (PMR) in a small single-arm trial, researchers said, suggesting another potential alternative to long-term ...

The US Food and Drug Administration (FDA) approved sarilumab (Kevzara) today for the treatment of polymyalgia rheumatica (PMR) in adults who have had an inadequate response to corticosteroids or could ...